![]() |
市場調查報告書
商品編碼
2026895
微型冷藏離心分離器市場預測至2034年—按類型、應用和地區分類的全球分析Micro Refrigerated Centrifuge Market Forecasts to 2034 - Global Analysis By Type (Floor-standing and Desktop), Application (Clinical Laboratories, Pharmaceuticals, Agricultural Research and Other Applications) and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球微型冷凍離心機市場規模將達到 10 億美元,並在預測期內以 7.5% 的複合年成長率成長,到 2034 年將達到 18 億美元。
微型冷凍離心機是一種專門的實驗室儀器,它利用離心力在溫度可控的環境下分離少量生物樣本。這些設備在多種應用中發揮著至關重要的作用,尤其是在分子生物學、生物化學和臨床診斷領域。透過快速旋轉樣品,離心機可以分離不同密度的顆粒和成分。它適用於在溫度控制下處理少量樣品,從而確保獲得準確可靠的結果。
實驗室現代化改造工作
自動化系統可以同時處理更多樣本,從而縮短實驗和診斷流程所需的時間。這在時間緊迫的應用中尤其重要,例如臨床診斷,因為快速獲得結果對患者照護至關重要。此外,自動化最大限度地減少了人工干預,降低了人為錯誤的風險,並確保多次運行結果的一致性。這提高了結果的可重複性,而可重複性是科學研究的關鍵要素,並正在推動市場擴張。
前期成本高
高昂的初始成本是一項挑戰,尤其對於預算有限或資金籌措緊張的檢查室和研究機構而言,這可能會阻礙那些考慮購買離心機以實現流程自動化的機構。此外,這也會影響潛在買家對投資報酬率 (ROI) 的計算。因此,這些離心機的製造和研發成本很高,導致售價虛高,並阻礙了市場成長。
技術進步
機器人技術的創新在實現精準的樣品處理方面發揮著至關重要的作用。先進的感測器技術提高了離心過程的精確度,確保在DNA/RNA萃取和蛋白質純化等應用中獲得最佳結果,並有助於產生高品質、可重複的數據。此外,與實驗室資訊系統(LIS)和數據管理軟體等智慧技術的整合,簡化了工作流程,並實現了對離心機運作狀態的即時監控,從而推動了市場成長。
缺乏標準化
缺乏標準化的協定和介面使資料管理和通訊變得複雜。不同製造商生產的離心機型號在設計、尺寸和規格上可能存在差異,導致難以整合到自動化系統中。此外,缺乏相容性使得實驗室在不大幅更改或重新配置自動化系統的情況下,難以輕鬆更換或升級離心機。這造成了互通性問題,可能會阻礙市場成長。
新冠疫情的影響
新冠疫情對自動化微型冷凍離心機市場造成了負面影響,影響了該產業的供需雙方。封鎖和限制措施導致實驗室運作和研究活動中斷,減緩了設備的採購和升級。此外,預算限制和優先事項的調整也導致自動化技術投資的延遲。這限制了實驗室投資新型、先進的自動化微型冷凍離心機的能力,嚴重阻礙了市場成長。
在預測期內,桌上型電腦市場預計將佔據最大佔有率。
桌上型離心機預計將佔據最大的市場佔有率,這主要得益於專為實驗室桌面設計的緊湊高效的離心系統。這些離心機的特點是面積小、操作簡單、控制系統先進,並且可程式設計功能,能夠簡化和自動化離心過程。此外,這些自動化桌上型離心機尤其適用於檢體製備、核酸萃取和蛋白質純化等應用,這也推動了該細分市場的成長。
預計在預測期內,臨床檢查室領域將呈現最高的複合年成長率。
預計在預測期內,臨床檢查室領域將呈現最高的複合年成長率。這些離心機專為滿足診斷檢查室和醫療機構的嚴格要求而設計。自動化功能包括可程式設計程式、觸控螢幕介面以及與實驗室資訊系統的整合。此外,這些技術進步有助於實現標準化、高通量的樣本處理,使臨床檢查室能夠準確、一致地處理大量樣本,從而推動該領域的成長。
在預測期內,歐洲佔據了最大的市場佔有率,這主要得益於對旨在實現高效自動化檢體處理的先進檢測設備的需求不斷成長。這些進步與該地區在科學研究和醫療保健領域的主導地位相符,並得益於其對技術創新的重視以及在包括分子生物學、生物化學和臨床診斷在內的各種應用領域中最佳化檢測工作流程的努力。
預計北美地區在預測期內將實現最高的複合年成長率。這些離心機旨在有效處理小體積樣本,並具備自動化功能,從而提高精度並最佳化工作流程。該地區匯集了久保田株式會社、日經電子株式會社、Axel World 和 Thermo Scientific 等知名企業。此外,具備自動化功能的微型冷凍離心機對於研究機構、製藥公司和臨床檢查室至關重要,推動了該地區的成長。
According to Stratistics MRC, the Global Micro Refrigerated Centrifuge Market is accounted for $1.0 billion in 2026 and is expected to reach $1.8 billion by 2034 growing at a CAGR of 7.5% during the forecast period. A micro refrigerated centrifuge is a specialized laboratory instrument designed for the separation of small volumes of biological samples through centrifugal force while also maintaining a controlled temperature environment. This device is crucial in various applications, particularly in molecular biology, biochemistry, and clinical diagnostics. This centrifuge operates by spinning samples at high speeds, causing particles or components with different densities to separate. It is suitable for handling small sample volumes with temperature control, ensuring accurate and reliable results.
Laboratory modernization initiatives
Automated systems can handle a higher volume of samples concurrently, reducing turnaround times for experiments and diagnostic procedures. This is particularly crucial in time-sensitive applications, such as clinical diagnostics, where rapid results are essential for patient care. Moreover, automation minimizes manual intervention, reducing the risk of human errors and ensuring consistent performance across multiple runs contributing to the reproducibility of results, a crucial factor in scientific research which are boosting this market expansion.
High initial costs
The high initial costs pose a challenge for laboratories and research facilities, particularly those with limited budgets or funding constraints, which could discourage prospective purchasers from implementing automation in their processes. Moreover, this also impacts the return on investment (ROI) calculations for potential buyers, and consequently, the manufacturing and development costs of these centrifuges are high, leading to elevated purchase prices that are impeding market growth.
Technological advancements
Innovations in robotics play a crucial role in enabling precise sample handling and processing. Advanced sensor technologies enhance the accuracy of centrifugation processes, ensuring optimal results in applications such as DNA/RNA extraction and protein purification, which contribute to the generation of high-quality, reproducible data. Additionally, integration with smart technologies, such as connectivity with laboratory information systems (LIS) and data management software, streamlines workflows and facilitates real-time monitoring of centrifuge operations, thereby driving market growth.
Lack of standardization
The absence of standardized protocols and interfaces complicates data management and communication. Different manufacturers may employ varying designs, sizes, and specifications for their centrifuge models, making it challenging to integrate them into automated systems. Furthermore, the lack of compatibility prevents laboratories from easily swapping or upgrading centrifuges without significant modifications or reconfiguration of the automation setup. This can lead to interoperability issues and hinder the market.
Covid-19 Impact
The COVID-19 pandemic has had negative impacts on the micro-refrigerated centrifuge automation market, affecting both demand and supply aspects of the industry. The disruptions in laboratory operations and research activities during lockdowns and restrictions have led to a slowdown in equipment purchases and upgrades. Furthermore, budget constraints and shifting priorities have resulted in postponed investments in automation technologies. This has limited the ability of laboratories to invest in new and advanced micro-refrigerated centrifuges with automation features, which has significantly hampered the market size.
The desktop segment is expected to be the largest during the forecast period
The desktop segment is estimated to hold the largest share due to compact and efficient centrifuge systems designed for use on laboratory desktops. These centrifuges are characterized by their smaller footprint and user-friendly features, advanced control systems, and programmable functionalities that streamline and automate centrifugation processes. In addition, these automated desktop centrifuges are particularly used in applications such as sample preparation, nucleic acid extraction, and protein purification, which are boosting this segment's expansion.
The clinical laboratories segment is expected to have the highest CAGR during the forecast period
The clinical laboratories segment is anticipated to have highest CAGR during the forecast period. These centrifuges are specifically designed to meet the stringent requirements of diagnostic laboratories and medical facilities. Automation features may include programmable protocols, touch-screen interfaces, and integration with laboratory information systems. Furthermore, these advancements contribute to standardized and high-throughput sample processing, allowing clinical laboratories to handle a large volume of samples with precision and consistency, which is driving this segment's growth.
Europe commanded the largest market share during the extrapolated period, owing to a growing demand for advanced laboratory equipment designed for efficient and automated sample processing. These advancements are led by the region's emphasis on technological innovation and a commitment to optimizing laboratory workflows with diverse applications, including molecular biology, biochemistry, and clinical diagnostics, aligning with the region's prominent position in scientific research and healthcare.
North America is expected to witness highest CAGR over the projection period. These centrifuges are designed to handle small sample volumes efficiently while incorporating automation for improved precision and workflow optimization. This region is home to some of the major players, including Kubota Corporation, Nicke-Electro Ltd., Axel Global, and Thermo Scientific. In addition, microrefrigerated centrifuges with automation features are integral to research institutions, pharmaceutical companies, and clinical laboratories, which are driving the growth of this region.
Key players in the market
Some of the key players in the Micro Refrigerated Centrifuge Market include Axel Global, Benchmark Scientific, Inc., Eppendorf AG, Esco Scientific, Gyrozen, Hermle Labortechnik GmbH, Hitachi Koki Co., Ltd., Kubota Corporation, lab Force, Nicke-Electro Ltd., Sartorius AG, Scilogex and Thermo Scientific.
In December 2023, Thermo Fisher Scientific Inc. announced a new partnership to improve the wellbeing and treatment outcomes of adolescents and young persons living with HIV in Nigeria, the country with the second largest HIV epidemic worldwide.
In July 2023, A new benchmark has launched to bring more clarity to the definition of a high-quality carbon credit, which companies are increasingly using to offset their climate impact.
In May 2023, Thermo Fisher, the world leader in serving science, has signed a Memorandum of Understanding ("MOU") with the National Research and Innovation Agency of Indonesia (BRIN, Badan Riset dan Inovasi Nasional) to enable and enhance the country's national research and innovation infrastructure and capability.